Medical News: Bevacizumab Value in Ovarian Cancer Questioned - in Clinical Context, Ovarian Cancer from MedPage Today
Links shared publicly online about this topic.
- 453total visits
Medical News: Bevacizumab Value in Ovarian Cancer Questioned - in Clinical Context, Ovarian Cancer from MedPage Today
The controversial targeted agent bevacizumab (Avastin) is not cost-effective for patients with advanced ovarian cancer, researchers reported.
View full resource at medpagetoday.com
Tags: Cancer, Colorectal Cancer Medication, Ovarian Cancer, Women's Health, Avastin, News, Medical
Most Recently Shared on March 8, 2011 at 10:02 pm By:
Bevacizumab Value in Ovarian Cancer Questioned (CME/CE, with video) http://bit.ly/g4wKpl
Advertisement
